Portfolio conflicts: when an investor is too close to your market
The investor who understands your market fastest may already back a competitor, so portfolio conflicts need checking before outreach.
You get the intro and it feels like the good kind. The partner replies in two hours, not two weeks. They ask sharp questions. They already know the three competitors you would have had to explain. Halfway through the second meeting you realize why: they know the space because they led the Series A of the company you spend every sales call trying to beat. The meeting was warm because it was research. You just walked them through your roadmap, your pricing logic, and the customer objection you have not solved yet, and now that lives in a firm that is paid to make your competitor win.
That is a portfolio conflict, and most founders discover them the expensive way. They discover them after the meeting, after the deck, sometimes after the term sheet falls apart because a partner two doors down said "we can't, we already have Acme." The fix is boring and it works: before any investor goes into your active outreach, you check what they already own, and you decide on purpose how to handle it.
Why the best-fit investor is often the worst risk
Investors concentrate. A fund that likes your category has usually already made a bet in it, because that is what conviction looks like on their side. So the exact signal that makes an investor attractive, deep knowledge of your space, is also the signal most correlated with a conflict. The founder instinct is to chase the investors who need the least education. That instinct points you straight at the ones most likely to have a competing position.
The cost is not only a wasted meeting. A conflicted investor who takes the meeting anyway gets three things from you: your current numbers, your strategy, and your unsolved problems. Some take the meeting precisely for that. Most are not malicious, they are curious, and curiosity inside a fund that backs your competitor is still a leak. You are not paranoid to treat the pitch as information disclosure, because that is what it is. The question is whether the person receiving it is aligned with you or with someone trying to kill you.
The four conflict types, and why they are not the same
"Conflict" gets used as one word for four different situations that need four different responses. Collapsing them is why founders either over-panic and skip good investors, or under-check and pitch a direct competitor's board member.
Direct competitor. The fund has a portfolio company that sells roughly what you sell to roughly who you sell to. This is the hard conflict. Most funds will not invest, and many partners will not take a real meeting, because their existing company would object and their own time is better spent elsewhere. Pitching here is the worst case: high leak risk, near-zero close probability.
Adjacent portfolio. The fund owns something next to you. Same buyer, different product. Same problem, different wedge. A fund that backed a CRM is not conflicted on your fundraising tool, but they might be if they see fundraising as a CRM feature. Adjacency is a judgment call, not a rule. Sometimes it is an advantage, because the partner already believes the buyer exists. Sometimes it is a slow conflict that surfaces only when your roadmap drifts into their company's lane.
Customer or supplier conflict. The fund's portfolio company is your customer, your channel, or your dependency. This one cuts both ways. A partner whose portfolio company relies on you has a reason to help. A partner whose portfolio company you are quietly planning to disintermediate has a reason to protect them and mine you. The conflict is about the commercial relationship, not the category.
Thesis conflict. No portfolio overlap, but the fund has published or repeated a thesis that your company contradicts. They believe the incumbent wins this market. They think your category is a feature, not a company. They wrote a post arguing the opposite of your core bet. There is nothing to disclose here, but there is a lot to not waste time on. You will spend the whole meeting arguing a prior instead of pitching a company.
How to research a conflict before you spend a meeting on it
You can clear most of this in ten minutes per fund, before the name ever reaches your outreach list. The research is not deep, it is systematic.
Start with the fund's portfolio page and read it as a competitor scan, not a highlight reel. You are looking for anything in your buyer, your problem, or your category. Then check the specific partner, not just the firm, because a partner's own deals matter more than the fund's total book. Read what the partner has written or said publicly, because thesis conflicts live in their posts and podcast appearances, not their portfolio. Search the competitor's own funding announcements, which name the lead and often the board member. Finally, if you have a warm connection into the fund, ask the plainest possible version: "Is there anything in your portfolio that would make this a conflict?" Good investors answer that honestly, because a surprise conflict wastes their time too.
Here is the checklist, the same five passes every time:
CONFLICT RESEARCH CHECKLIST (per fund, before outreach) [ ] Portfolio scan: any company sharing your buyer, problem, or category? [ ] Partner-level check: what has THIS partner led, not just the firm? [ ] Public thesis: posts, podcasts, tweets that contradict your core bet? [ ] Competitor funding: who led your rivals' rounds, and who sits on the board? [ ] Warm-path ask: can someone confirm "any conflict here?" before you pitch?
The decision: pitch, disclose, nurture, or avoid
Finding a conflict does not automatically mean skip the investor. It means pick a response on purpose. Four conflict types map to four moves.
| Conflict type | Default move | What you actually do | What you withhold |
|---|---|---|---|
| Direct competitor | Avoid | Do not pitch. Optionally keep a light relationship for later, when they've exited the competing position. | Everything specific: numbers, strategy, roadmap. |
| Adjacent portfolio | Disclose + pitch | Name the adjacency in the first email. Ask directly if they see it as a conflict. Pitch normally if they say no. | Nothing unusual, once they've cleared it. |
| Customer / supplier | Disclose + pitch carefully | Name the relationship. Pitch, but keep any plan that competes with their portfolio company vague until there's a term sheet. | Specific plans to disintermediate their company. |
| Thesis conflict | Nurture, don't pitch now | Skip the raise pitch. Send updates that chip at the thesis with evidence. Pitch a future round once the prior has moved. | Your time in a live round. |
The rule underneath the table: withholding scales with leak risk, and effort scales with close probability. A direct competitor gets no information and no meeting during a live round. An adjacency that clears gets a normal pitch. A thesis conflict gets patience, because the fastest way to lose a raise is to spend three meetings converting someone who was never going to move inside your timeline.
One line does most of the work in the disclose cases. Put it in the first email, not the third meeting: "I noticed you've backed [Company]. I see us as adjacent rather than competing because [one specific reason], but wanted to flag it up front. If you see it differently, no hard feelings." That sentence does two things. It shows you did the work, which reads as operator seriousness. And it moves the conflict conversation to minute one, when it costs you an email, instead of week three, when it costs you a term sheet.
What this looks like across a whole list
Run the check once, at list-build time, and tag every investor with a conflict status. Then your outreach wave carries the decision with it, instead of you re-deciding under pressure when a warm intro lands. A tagged list might look like this:
INVESTOR CONFLICT TYPE STATUS NOTE Fund A Direct competitor AVOID Led Acme's A. Do not pitch this round. Fund B Adjacent DISCLOSE Owns a CRM. Flag adjacency in email 1. Fund C None PITCH Clean. Prioritize. Fund D Thesis NURTURE Partner wrote "this is a feature." Updates only. Fund E Customer conflict DISCLOSE Portfolio co is a target customer. Pitch, guard roadmap.
The value is not the tag. It is that the decision was made when you were calm and researching, not when an intro to a direct competitor's lead investor arrives on a Friday and you take the meeting because saying no feels rude.
Where RoundOS fits
This is the kind of check that is obvious once and forgotten a hundred times. You build the list over weeks, intros arrive out of order, and by the time Fund A shows up as a warm intro you have forgotten they led your competitor's round. RoundOS enriches each investor and fund from the sources you already have, then holds the conflict tag on the record, so the flag travels with the name into your decision queue. When an intro to a conflicted fund lands, the next-move view surfaces the tag before you reply, instead of after you have pitched. The conflict decision you made once at list-build time is the one you act on, even three weeks and forty investors later.
Reusable artifact: the conflict decision flow
For each investor before they enter the outreach wave:
1. Portfolio scan → any company in your buyer/problem/category?
NO → check thesis. Clean? → PITCH.
YES → go to 2.
2. Is it the same product to the same buyer?
YES → DIRECT COMPETITOR → AVOID (no meeting, no info this round).
NO → go to 3.
3. Is the overlapping company your customer, channel, or dependency?
YES → CUSTOMER/SUPPLIER → DISCLOSE + pitch, guard competing roadmap.
NO → ADJACENT → DISCLOSE adjacency in email 1, pitch if cleared.
4. No portfolio overlap but a published thesis against your bet?
YES → THESIS CONFLICT → NURTURE with evidence, pitch a later round.Check conflicts before the pitch.
Before you add the next batch of names to your active outreach wave, run the five-pass conflict check on each and tag them pitch, disclose, nurture, or avoid. If a fund comes back a direct competitor, pull it from this round's list now, while it costs you nothing.